Atlantic Research Grouphttps://atlanticresearchgroup.com/
- Founded: 2004
- CEO: Paul Bishop
- Size of Facility: 12,000 sf
- Company Size: 100
- Funding Source: Privately Held
- Development Stage: Phase 1-2 Clinical Trials, Phase 3 Clinical Trial
ARG is a rare disease, oncology and immunology-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. Founded in 2004, ARG has experienced consistent growth across the globe, expanding our reach to include drug and device trial management in diverse and wide-ranging therapeutic areas. ARG has remained true to our original vision: every project is highly significant and visible, delivered through strategic collaboration with partners. ARG is rare for a reason: we successfully operationalize orphan development projects because we believe everyone deserves to be well.